Fasting plasma glucose is an independent determinant of left ventricular diastolic dysfunction in nondiabetic patients with treated essential hypertension

Hypertension Research

Volumn 25, Issue 3, 2002, Pages 403-409

  Miyazato, Junko ^a   Horio, Takeshi ^a   Takishita, Shuichi ^a   Kawano, Yuhei ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Diastolic function; Glucose; Hypertension; Hypertrophy; Ventricles

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CALCULATION; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DECELERATION; DIABETES MELLITUS; DOPPLER ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD; DIASTOLE; DIET RESTRICTION; HYPERTENSION; INSULIN RESISTANCE; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; DIASTOLE; FASTING; FEMALE; HUMAN; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; MIDDLE AGE; VENTRICULAR DYSFUNCTION, LEFT; HUMANS; MIDDLE AGED;

EID: 0035991136     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.403     Document Type: Article

References (44)

1. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
2. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
3. Prognostic significance of abnormal peak early to late diastolic filling ratio in middle-aged to elderly adult American Indians: The Strong Heart Study
4. Left ventricular diastolic dysfunction as a cause of congestive heart failure: Mechanisms and management
5. Congestive heart failure with normal systolic function
6. Intact systolic left ventricular function in clinical congestive heart failure
7. Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients
8. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: The Strong Heart Study
9. Effect of blood glucose on left ventricular mass in patients with hypertension and type 2 diabetes mellitus
10. Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)
11. Epidemiology and risk profile of cardiac failure
12. Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: The Framingham Study
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
14. Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension
15. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method
16. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography
17. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study
18. The importance of age and obesity on the relation between diabetes and left ventricular mass
19. Left ventricular diastolic filling in diabetes mellitus with and without hypertension
20. Doppler diastolic filling indexes in relation to disease states
21. Role of hypertension, diabetes, obesity, and race in the development of symptomatic myocardial dysfunction in a predominantly minority population with normal coronary arteries
22. Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance
23. Role of glucose intolerance in cardiac diastolic function in essential hypertension
24. Left ventricular diastolic function in hypertension and role of plasma glucose and insulin: Comparison with diabetic heart
25. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model
26. Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension
27. Insulin resistance and cardiovascular complications in patients with essential hypertension
28. Diabetic cardiomyopathy
29. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease
30. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome
31. Is insulin action a determinant of left ventricular relaxation in uncomplicated essential hypertension?
32. Diastolic function and insulin resistance in essential hypertension
33. Insulin and diastolic dysfunction in lean and obese hypertensives: Genetic influence
34. Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension
35. Independent association of plasma leptin levels and left ventricular isovolumic relaxation in uncomplicated hypertension
36. Serum insulin levels, 24-hour blood pressure profile, and left ventricular mass in nonobese hypertensive patients
37. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension
38. Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans
39. Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension
40. Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry
41. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler cardiographic study
42. Quantitative hemodynamics by Doppler echocardiography: A noninvasive alternative to cardiac catheterization
43. Evaluation of left ventricular diastolic function: Clinical relevance and recent Doppler echocardiographic insights
44. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients